Ispecimen Inc is a biotechnology company focused on enhancing the accessibility of biospecimens for research and clinical purposes. By leveraging advanced technology and an extensive network of biorepositories, Ispecimen facilitates the collection, management, and distribution of human biological samples, thereby accelerating medical research and development. Their platform aims to streamline the process for academia, pharmaceutical companies, and other organizations in need of high-quality biospecimens, ultimately contributing to advancements in personalized medicine and healthcare solutions. Read More
WOBURN, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of its previously announced underwritten public offering of 5,714,283 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.70 per share (the “Offering”). The aggregate gross proceeds to the Company from the Offering was approximately $4 million, before deducting underwriting discounts and commissions and other offering expenses.
WOBURN, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the pricing of an underwritten public offering of 5,714,283 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.70 per share (the “Offering”). The aggregate gross proceeds to the Company from the Offering are expected to be approximately $4 million, before deducting underwriting discounts and commissions and other estimated offering expenses. The Offering is expected to close on July 25, 2025, subject to the satisfaction of customary closing conditions.
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
On Thursday morning, iSpecimen Inc. (NASDAQ: ISPC) attracted significant investor attention with a 48% premarket jump to $6.60. While momentum eased after the open, ISPC bulls remained in control, ending the day with an impressive 11% gain and trading volume over ten times its usual average. Incidentally, that jump was well-deserved.
The premarket surge in iSpecimen Inc. (NASDAQ: ISPC) on Thursday caught the attention of many, with the stock leaping 48% to $6.60 at the early morning’s peak. While it moderated slightly after the opening bell, iSpecimen maintained momentum, closing up over 11% amid, a trading volume more than ten times its daily average.
The premarket surge in iSpecimen Inc. (NASDAQ: ISPC) on Thursday may have surprised some investors, but certainly not all. Those familiar with this innovative company can quickly point to an evidence-based case for why ISPC stock jumped 48% to $6.60. While it retreated to start the regular session, the bulls remained firmly in control of the trading-day narrative, with shares closing Thursday higher by over 11% on over 10x average volume.
